International cooperation

Research and Development

Department of Allergology and Clinical Immunology, KazNMU

Considerable attention is paid to research work. The Department of Allergology works closely with the European Academy of Allergology and Clinical Immunology (EAACI) and has signed a cooperation agreement with the Medical University of Vienna.

Since 1998, the International National Congress “Asthma and Allergy” has been held annually, featuring world-renowned experts and leading specialists from near and far abroad.

Historical Milestone: In 2013, the Allergology and Clinical Immunology Association (AACI) joined the EAACI as an equal member for the first time in Kazakhstan’s history.

This led to the 2014 first Congress of Allergists of the RK, with the participation of global leaders: Prof. Nikolaos Papadopoulos (Manchester), Prof. Winfried Pickl, and Prof. Rudolf Valenta (Vienna).

Professors Rudolf Valenta, Winfried Pickl, V. Gharib, and Nikolaos Papadopoulos.

Antti Lauerma (Finland), Ispayeva Zh.B. (Kazakhstan), Hannes Stokinger (Austria).

International Recognition

For the first time, AACI presented Kazakhstan’s achievements at the EAACI exhibition. Young faculty members won the EFIS Travel Awards and participated in the International School of Molecular Allergology in Georgia, receiving top prizes.

Ongoing Scientific Programs

National Program (2021-2023)

Implementation of Personalized and Preventive Medicine in the Republic of Kazakhstan.
Focus: “Bronchial Asthma in the Kazakh Population” — Lead: Prof. Zhanat Ispayeva.

2021–2023 Key Results:

4 scientific publications (International & Domestic)

1 copyright certificate, 1 patent received

Full implementation in medical practice

2021–2022 Biobank Project:

Creation of a panel of donor samples with atopic dermatitis for drug development and diagnostic testing.

Roxall Group International Clinical Trials

2023–2025: Phase II–III studies on subcutaneous cluster immunotherapy (grass pollen).

2025–2027 Upcoming Trials:

🛡️ SC-3F2A: Cluster Immunotherapy (Birch Pollen) — Phase II–III.

🛡️ SC-3Q2A: Sublingual Immunotherapy (Birch Pollen) — Phase II–III.

Team-Based Learning (TBL)

Topic: “Bronchial Asthma, Status Asthmaticus” implemented for 5th-year medical students.

Simulation Training

Topic: “Anaphylactic Shock” — Emergency management training for outpatient care specialists.

Global Recognition: GA²LEN Accreditation

On October 17, 2025, the Allergy Department successfully passed the international audit by world expert Prof. Maia Gotua. The department is now officially part of the Global Allergy and Asthma European Network:

UCARE (Urticaria)
ADCARE (Atopic Dermatitis)
ACARE (Angioedema)

This integration into GA²LEN reference centers opens prospects for international scientific collaboration, innovative diagnostics, and global expert interaction.

Audit Preparation Team: Prof. Zhanat Ispayeva, R. Bekmagambetova, A. Seitbattalova, A. Sarsenbayeva. Residents: K. Ashurbekova, M. Zhumash, A. Turganbayev.

© 2026 Asfendiyarov KazNMU | Department of Allergology and Clinical Immunology